Stroke $STOK Therapeutics IPOs For Dravet Syndrome Cure
Manage episode 348584109 series 3183535
STOK stock will be listed today, IPOing at $18, market cap of ~$550mm. They have a drug for treating Dravet Syndrome which is in in Phase 3 trials.
Show notes:
~greetings and salutations~
$STOK: Stroke Therapeutics
$ADBE: Adobe
$AXTA: Axalta Coating
~intermission~
$IRWD: Ironwood Pharma
$MLNT: Melinta
~fin~
50 episoder